Bottom line
THISX vs FHLC: the short answer
THISX (T. Rowe Price Health Sciences Fund, Inc.) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
FHLC is cheaper at 0.084% vs 0.68% — a difference of $60 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +4.3% for THISX (reporting dates differ).
Updated Nov 19, 2026
THISX vs FHLC side by side
| THISX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | T. Rowe Price | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.68% | 0.084% |
| Annual cost per $10k | $68 | $8.4 |
| 10-yr cost on $10k (prospectus) | $847 | $108 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.9% | +2.6% |
| 5-yr return (annualized) | +4.3% | +7.2% |
| 10-yr return (annualized) | — | +8.8% |
| Best quarter | +23.5% | +16.4% |
| Worst quarter | −15.8% | −13.1% |
| Net assets (fund) | $11.9B | $3.3B |
| Number of holdings | 279 | 337 |
| Portfolio turnover | 62% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of THISX's top 25 holdings also appear in FHLC's top 25.
| Holding | THISX | FHLC |
|---|---|---|
| Eli Lilly & Co | 14.28% | 13.35% |
| Johnson & Johnson | 6.63% | 8.93% |
| Unitedhealth Group Inc | 5.99% | 5.44% |
| Abbvie Inc | 5.10% | 6.42% |
| Merck & Co. Inc. | 4.01% | 4.66% |
| Gilead Sciences Inc | 2.82% | 2.34% |
| Thermo Fisher Scientific Inc | 2.52% | 3.09% |
| Vertex Pharmaceuticals Inc | 2.28% | 1.76% |
| Bristol-myers Squibb Co | 2.11% | 1.93% |
| Abbott Laboratories | 1.89% | 2.66% |
| Intuitive Surgical Inc | 1.87% | 1.82% |
| Amgen Inc | 1.82% | 3.00% |
| Stryker Corp | 1.78% | 1.62% |
| Elevance Health Inc | 1.53% | 1.19% |
| Danaher Corp | 1.43% | 1.80% |
Source: SEC Form N-PORT
THISX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between THISX and FHLC?
THISX (T. Rowe Price Health Sciences Fund, Inc.) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds. FHLC is cheaper at 0.084% vs 0.68% — a difference of $60 a year per $10,000 invested.
Which is cheaper, THISX or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both THISX and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.